North Carolina Translational and Clinical Science Institute (NC TraCS) KL2
北卡罗来纳州转化与临床科学研究所 (NC TraCS) KL2
基本信息
- 批准号:10116520
- 负责人:
- 金额:$ 190.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-03-30 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAdvisory CommitteesBackClinical SciencesCollaborationsCompetenceDevelopmentDisciplineEducational CurriculumElementsEnvironmentFacultyFeedbackFundingGoalsGrantHomeIndustryInstitutesInterdisciplinary StudyLeadershipLearningMentorsMethodologyNatureNorth CarolinaPathway interactionsPeer GroupPeer ReviewPhilosophyPositioning AttributePrincipal InvestigatorProgram DevelopmentResearchResearch PersonnelSchoolsScienceShapesTeacher Professional DevelopmentThinkingTimeTrainingTraining ActivityTraining ProgramsTranscendTranslational ResearchUniversitiesWorkWorkforce Developmentcareer developmentexperienceinnovationmembernext generationnovelpeerprogramsresiliencerole modelskillssuccesstranslational research programtranslational scientist
项目摘要
I. Institutional Career Development Core Abstract
The UNC/TraCS KL2 is the flagship program through which we shape the development of junior translational
scientists to become Principal Investigators and research leaders. Since our inception, we have funded 63
Scholars: 15 are currently supported on the KL2, and 48 have completed the Program. Of these 48, 46 are
funded academic investigators; one is a clinician; and one holds a research position in industry. Our success to
date is exemplified by the fact that 73% of our “graduated” Scholars have received significant (over $100,000
for a single grant) independent PI funding within 54 months of their starting the KL2. Our Scholars represent 6
Schools and 17 departments, a diversity that not only distinguishes this KL2 from other training programs on
campus, but also encourages and facilitates translational collaborations among Scholars who might not
otherwise cross paths. This highly successful program is grounded in a philosophy of team science across
disciplines, schools, and centers/institutes; an outstanding corps of expert faculty who are committed to work
closely with the mentors and Scholars as part of a coordinated team approach to faculty development; program
leadership that keeps abreast of the evolving scientific and programmatic priorities of the CTSA Program; and
a collegial culture in which our former Scholars willingly continue to be engaged and give time and expertise
back to the program as role models, mentors, and collaborators.
Going forward, the KL2 Program is adapting to the changing nature of our applicant pool and the evolving
translational workforce pipeline by replacing the mandatory two-year curriculum with personalized training
pathways developed by Scholars in collaboration with KL2 program faculty and their mentors. In addition, we
have established the KL2 Alumni Advisory Team, in which KL2 graduates provide feedback about training
components and advice on new content or redesign of how current content is delivered. Other changes include
increasing collaborative activities with the CTSA Consortium, integrating new initiatives such as the NCATS
Trial Innovation Network and TraCS Workforce Development Program into training activities, expanding
activities in mentoring, and introducing a set of competencies in scientific and research leadership. Goal 1:
Train KL2 Scholars to apply their disciplinary expertise to translational science and equip them with the
strategic thinking and management skills needed to create and sustain transformative interdisciplinary
translational research programs in a rapidly changing environment. Goal 2: Provide KL2 Scholars with the
skills to mentor members of their own research teams as well as the next generation of investigators.
TraCS serves as a true “home” for early-stage researchers who wish to engage in shared learning, peer review
and, most importantly, the development of a peer group that encourages innovation, resilience, and retention in
science. Our KL2 Program provides Scholars with experiences that enable them to transcend methodologic
boundaries, adopt concepts from other disciplines, and produce truly transformative translational science.
I. Internitation Paresspent Core摘要
UNC/TRACS KL2是旗舰计划,我们塑造了初级翻译的发展
科学家成为主要研究人员和研究领袖。
学者:目前在KL2上支持15个,而48个计划已完成。
资助的研究人员是一个临床医生;
我们的“毕业”学者中有73%获得了大量的事实(超过$ 100,000),这证明了日期
单一赠款)在我们的KL2开始后的54个月内,独立的Pi Fithing 6。
学校和17个部门,这不仅将KL2与其他有关的培训计划区分开
校园,但也鼓励和促进了可能不不不不通知的学者之间的转化合作
否则,这个非常成功的计划是基于团队科学哲学
学科,学校和中心/机构;
与导师和校友紧密相关,作为协调的团队发展方法的一部分
领导CTSA计划的进化科学和程序重点的关键;
我们以前的学者愿意继续进行的一种合作文化
返回该计划作为榜样,导师和合作者。
展望未来,KL2计划正在适应我们的申请人池和不断发展的变化
由强制性的两年课程通过个性化培训,翻译员工管道
由学者与KL2计划的教职员工合作开发的途径
已经建立了KL2校友咨询团队
关于新内容的组件和建议或重新设计当前内容的交付方式。
增加与CTSA财团的协作活动,集成了NCAT等新计划
试用创新网络和培训计划中的培训活动,扩展
指导的激活,并在科学和研究领导中引入一系列能力。
训练KL2学者运用其纪律专业知识翻译科学,并为他们配备何处。
建立和维持变革性跨学科所需的战略思维和管理技能
在快速变化的环境中的转化研究计划2:为KL2学校提供。
指导自己的研究团队的技能和诱人者一样。
对于希望共享,同行评审的早期研究人员来说,TRAC是真正的“家”
而且,最重要的是,鼓励创新和退位的同伴群体的发展
科学。
界限,采用其他其他学科的概念,并产生崩溃的翻译科学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Morris Weinberger其他文献
Morris Weinberger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Morris Weinberger', 18)}}的其他基金
North Carolina Translational and Clinical Science Institute (NC TraCS) KL2
北卡罗来纳州转化与临床科学研究所 (NC TraCS) KL2
- 批准号:
10362720 - 财政年份:2018
- 资助金额:
$ 190.03万 - 项目类别:
CTSA KL2 Supplement Rebecca Grzadzinski
CTSA KL2 补充 Rebecca Grzadzinski
- 批准号:
10117614 - 财政年份:2018
- 资助金额:
$ 190.03万 - 项目类别:
UNC Mentored Career Development Program in Comparative Effectiveness Research
北卡罗来纳大学比较有效性研究指导职业发展计划
- 批准号:
8016132 - 财政年份:2010
- 资助金额:
$ 190.03万 - 项目类别:
COMMUNITY BASED PHARMACEUTICAL CARE--A CONTROLLED TRIAL
基于社区的药物治疗——对照试验
- 批准号:
2237446 - 财政年份:1996
- 资助金额:
$ 190.03万 - 项目类别:
COMMUNITY-BASED PHARMACEUTICAL CARE: A CONTROLLED TRIAL
基于社区的药物治疗:对照试验
- 批准号:
2714192 - 财政年份:1996
- 资助金额:
$ 190.03万 - 项目类别:
COMMUNITY-BASED PHARMACEUTICAL CARE: A CONTROLLED TRIAL
基于社区的药物治疗:对照试验
- 批准号:
2430868 - 财政年份:1996
- 资助金额:
$ 190.03万 - 项目类别:
COMMUNITY-BASED PHARMACEUTICAL CARE: A CONTROLLED TRIAL
基于社区的药物治疗:对照试验
- 批准号:
6017350 - 财政年份:1996
- 资助金额:
$ 190.03万 - 项目类别:
COST-BENEFIT OF EASING BURDEN OF ALZHEIMERS CAREGIVERS
减轻阿尔茨海默病护理人员负担的成本效益
- 批准号:
3056619 - 财政年份:1989
- 资助金额:
$ 190.03万 - 项目类别:
COST-BENEFIT OF EASING BURDEN OF ALZHEIMERS CAREGIVERS
减轻阿尔茨海默病护理人员负担的成本效益
- 批准号:
3056618 - 财政年份:1989
- 资助金额:
$ 190.03万 - 项目类别:
相似海外基金
Futureproofing Health: Developing a Center for Resilient Health in Disasters
面向未来的健康:建立灾难恢复健康中心
- 批准号:
10835244 - 财政年份:2023
- 资助金额:
$ 190.03万 - 项目类别:
Structural regulation of megalin recycling in the proximal tubule
近曲小管巨蛋白循环的结构调节
- 批准号:
10802792 - 财政年份:2023
- 资助金额:
$ 190.03万 - 项目类别:
Exercise-induced Legacy Health Benefits on Cardiometabolic Risk Factors in Aging Adults with Prediabetes
运动对患有前驱糖尿病的老年人的心脏代谢危险因素的传统健康益处
- 批准号:
10353779 - 财政年份:2022
- 资助金额:
$ 190.03万 - 项目类别:
Exercise-induced Legacy Health Benefits on Cardiometabolic Risk Factors in Aging Adults with Prediabetes
运动对患有前驱糖尿病的老年人的心脏代谢危险因素的传统健康益处
- 批准号:
10559632 - 财政年份:2022
- 资助金额:
$ 190.03万 - 项目类别:
Building blocks for an HIV-NCD integration Community-Clinical Linkage Model TO enhance the MAP-IT Study: Link2MAP-IT
HIV-NCD 整合社区临床联系模型的构建模块以增强 MAP-IT 研究:Link2MAP-IT
- 批准号:
10827187 - 财政年份:2020
- 资助金额:
$ 190.03万 - 项目类别: